CS168036B2 - - Google Patents

Info

Publication number
CS168036B2
CS168036B2 CS4540A CS454073A CS168036B2 CS 168036 B2 CS168036 B2 CS 168036B2 CS 4540 A CS4540 A CS 4540A CS 454073 A CS454073 A CS 454073A CS 168036 B2 CS168036 B2 CS 168036B2
Authority
CS
Czechoslovakia
Application number
CS4540A
Other languages
Czech (cs)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS168036B2 publication Critical patent/CS168036B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS4540A 1972-07-01 1973-06-25 CS168036B2 (index.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6630172A JPS5512435B2 (index.php) 1972-07-01 1972-07-01

Publications (1)

Publication Number Publication Date
CS168036B2 true CS168036B2 (index.php) 1976-05-28

Family

ID=13311838

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4540A CS168036B2 (index.php) 1972-07-01 1973-06-25

Country Status (15)

Country Link
US (1) US3925357A (index.php)
JP (1) JPS5512435B2 (index.php)
AT (1) AT325206B (index.php)
AU (1) AU469986B2 (index.php)
BE (1) BE801588A (index.php)
CA (1) CA996548A (index.php)
CH (1) CH573435A5 (index.php)
CS (1) CS168036B2 (index.php)
DE (1) DE2332840A1 (index.php)
FR (1) FR2190414B1 (index.php)
GB (1) GB1386566A (index.php)
HU (1) HU166029B (index.php)
NL (1) NL7308048A (index.php)
PL (1) PL92969B1 (index.php)
SE (1) SE402916B (index.php)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522148U (index.php) * 1978-07-29 1980-02-13
DE50209483D1 (de) * 2001-02-24 2007-03-29 Boehringer Ingelheim Pharma Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
US20030171424A1 (en) * 2002-03-07 2003-09-11 Lin Ai J. Intravenous formulation of artelinic acid for treatment of severe and complicated malaria
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) * 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
NZ600394A (en) * 2006-05-04 2014-04-30 Boehringer Ingelheim Int Polymorphs of a dpp-iv enzyme inhibitor
NZ600126A (en) * 2007-08-17 2013-12-20 Boehringer Ingelheim Int Purine derivatives for use in the treatment of fap-related diseases
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
BRPI0917675A2 (pt) * 2008-08-15 2015-12-01 Boehringer Ingelheim Int compostos orgânicos para cura de ferida
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
KR20110103968A (ko) 2008-12-23 2011-09-21 베링거 인겔하임 인터내셔날 게엠베하 유기 화합물의 염 형태
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20190071840A (ko) 2009-11-27 2019-06-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
PH12012502162A1 (en) 2010-05-05 2013-02-04 Boehringer Ingelheim Int Combination therapy
EP2585101A1 (en) 2010-06-24 2013-05-01 Boehringer Ingelheim International GmbH Diabetes therapy
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
EP3517539B1 (en) 2011-07-15 2022-12-14 Boehringer Ingelheim International GmbH Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
US9526728B2 (en) 2014-02-28 2016-12-27 Boehringer Ingelheim International Gmbh Medical use of a DPP-4 inhibitor
KR102391564B1 (ko) 2016-06-10 2022-04-29 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴 및 메트포르민의 병용물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1026793A (fr) * 1949-08-02 1953-05-04 American Cyanamid Co Procédé de préparation de sels de pénicilline
NL6803062A (index.php) * 1967-03-10 1968-09-11
US3557094A (en) * 1968-01-05 1971-01-19 Pfizer & Co C Substituted alkyl esters of alpha-carboxy aryl penicillins
AT290728B (de) * 1968-09-28 1971-05-15 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer penicilline

Also Published As

Publication number Publication date
FR2190414A1 (index.php) 1974-02-01
PL92969B1 (index.php) 1977-04-30
AT325206B (de) 1975-10-10
DE2332840A1 (de) 1974-01-17
SE402916B (sv) 1978-07-24
AU5760073A (en) 1975-01-09
GB1386566A (en) 1975-03-12
US3925357A (en) 1975-12-09
HU166029B (index.php) 1974-12-28
JPS5512435B2 (index.php) 1980-04-02
FR2190414B1 (index.php) 1976-07-02
BE801588A (fr) 1973-12-28
CA996548A (en) 1976-09-07
JPS4925121A (index.php) 1974-03-06
NL7308048A (index.php) 1974-01-03
AU469986B2 (en) 1976-02-26
CH573435A5 (index.php) 1976-03-15

Similar Documents

Publication Publication Date Title
CS167376B2 (index.php)
CS166850B2 (index.php)
CS152738B1 (index.php)
CS154027B1 (index.php)
CS154185B1 (index.php)
CS155396B1 (index.php)
CS155639B1 (index.php)
CS164445B1 (index.php)
CS163916B1 (index.php)
CS158011B1 (index.php)
CS156832B1 (index.php)
CS155927B1 (index.php)
BG17364A1 (index.php)
CH576702A5 (index.php)
CH559862A5 (index.php)
CH560788A5 (index.php)
CH561520A5 (index.php)
CH562710A5 (index.php)
CH563508A5 (index.php)
CH564727A5 (index.php)
CH565313A5 (index.php)
CH565365A5 (index.php)
CH565481A5 (index.php)
CH567260A5 (index.php)
CH559258A (index.php)